堃博医疗控股有限公司（股票代码：02216）于2026年9月4日发布了截至2026年8月31日的证券变动月报表。报告显示，公司在本月期间未发生新增股份发行、股份回购或注销，相关股本保持稳定。
根据公告，公司的法定/注册股本维持在2,000,000,000股，面值每股USD 0.000025，总额USD 50,000。已发行股份（不含库存股份）数量为527,079,084股，库存股份1,658,000股，均与上月底一致，无变化。公司同时确认已满足上市监管要求的公众持股量规定。
在股权激励方面，截至本月末，根据2021年5月9日采纳的股份激励计划，尚有2,220,664份已授出的股份期权，报告期内并无任何股权期权行使、注销或失效情形，其中1,997,017股仍为可行使的股份数目。公司亦披露，受限制股份单位计划（RSU计划）当月未进行任何新股发行或库存股份转让。
公告最后显示，公司各项发行及库存股份出售或转让均符合香港联交所《上市规则》及相关法律法规的要求。公告由公司董事徐宏签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.